Psychosis | CHOP Research Institute


Published on
Jul 8, 2024
Dr. Jerome Taylor and colleagues are studying oxidative stress as a potential treatable biomarker of psychosis in adolescents.

Dr. Taylor's translational and clinical research program focuses on preventing disorders like schizophrenia and bipolar disorder with psychotic features. He is particularly interested in the roles that oxidative stress and neuroinflammation play in psychosis symptom progression in youth.

taylorj14 [at]

LiBI conducts research in children, adolescents, and adults to study how brain and behavior change over time and in response to illness, with a focus on risk and resilience factors. Areas of research include behavior, cognition, environmental risk, genetics, neuroimaging, and animal models.

Published on
Aug 14, 2020
In the News this week features a Humanitarian Award, along with research on psychosis, antibiotics continuous glucose monitoring and DNA methylation.

The Brain-Gene-Development Lab investigates psychiatric risk using a multi-faceted approach that combines neuroimaging, genomics, and clinical phenomics.

Dr. Alexander-Bloch investigates normal brain development and the altered developmental trajectories that lead to mental illness. His multi-disciplinary research integrates brain imaging, genomics and clinical information.

alexanderba [at]
Published on
Dec 18, 2018
A new study from the Lifespan Brain Institute sheds light on the obsessive compulsive patterns associated with serious psychopathology in youth.
Published on
May 9, 2017
Synapses were firing throughout the conference room in the Colket Translational Research Building as attendees at the 2017 Research Institute Scientific Symposium held May 2 learned about their colleagues' intriguing research endeavors. The four sessions' themes aligned smartly with the Research Institute's strategic planning process and overall mission of the Children's Hospital of Philadelphia.